Linezolid is not suitable as internal standard

J. W. C. Alffenaar; B. Greijdanus

doi:10.1016/j.jpba.2009.09.018

Linezolid is not suitable as internal standard

J. W. C. Alffenaar^*, B. Greijdanus

^*Corresponding author for this work

Faculty of Medical Sciences/UMCG

Research output: Contribution to journal › Letter › Academic › peer-review

Original language	English
Pages (from-to)	795-795
Number of pages	1
Journal	Journal of Pharmaceutical and Biomedical Analysis
Volume	51
Issue number	3
DOIs	https://doi.org/10.1016/j.jpba.2009.09.018
Publication status	Published - 5-Feb-2010

Keywords

Internal standard
Azole
Antifugal drugs
Therapeutic drug monitoring

Access to Document

10.1016/j.jpba.2009.09.018

Handle.net

Persistent link

Cite this

@article{a9113daad16543a4ab45a1114383b326,

title = "Linezolid is not suitable as internal standard",

keywords = "Internal standard, Azole, Antifugal drugs, Therapeutic drug monitoring",

author = "Alffenaar, {J. W. C.} and B. Greijdanus",

year = "2010",

month = feb,

day = "5",

doi = "10.1016/j.jpba.2009.09.018",

language = "English",

volume = "51",

pages = "795--795",

journal = "Journal of Pharmaceutical and Biomedical Analysis",

issn = "0731-7085",

publisher = "ELSEVIER SCIENCE BV",

number = "3",

}

TY - JOUR

T1 - Linezolid is not suitable as internal standard

AU - Alffenaar, J. W. C.

AU - Greijdanus, B.

PY - 2010/2/5

Y1 - 2010/2/5

KW - Internal standard

KW - Azole

KW - Antifugal drugs

KW - Therapeutic drug monitoring

U2 - 10.1016/j.jpba.2009.09.018

DO - 10.1016/j.jpba.2009.09.018

M3 - Letter

SN - 0731-7085

VL - 51

SP - 795

EP - 795

JO - Journal of Pharmaceutical and Biomedical Analysis

JF - Journal of Pharmaceutical and Biomedical Analysis

IS - 3

ER -